When it comes to making a difference in people’s lives, it’s not how many medicines you have, but having ones that work.
Medicines and medical devices funded for use in the community (Section B) and in DHB hospitals (Section H).
Alprazolam, amisulpride, atorvastatin, goserelin and leuprorelin, sumatriptan, venlafaxine.
Consultations, notifications, tenders, RFPs, media.
How medicines are funded, about medicines, making best use of medicines, hospital pharmaceuticals, hospital medical devices.
Guide to PHARMAC, how we work (OPPs), advisory committees, PTAC minutes, performance, history, people, vacancies.
He Rongoā Pai - He Oranga Whānau, Hiwinui Heke scholarships, Te Whaioranga Māori Responsiveness Strategy, PHARMAC whānau.
Named Patient Pharmaceutical Assessment (NPPA) and other channels for exceptional circumstances.
...people using medicines & medical devices, prescribers, pharmacists, suppliers, DHBs.
How we’re improving value in medical devices, hospital medicines, and through our use of evidence.
Quality over quantity more important in health outcomes.
High-quality education seminars for health professionals.
See how PHARMAC's work in funding medicines has affected New Zealanders over the last 10 years.
PHARMAC has changed the way it makes decisions.
Two new treatments for hepatitis C are now funded. Here's how to get them.
PHARMAC's role in managing hospital medical devices.
Track medicines going through PHARMAC's funding process.
A framework for funding in exceptional circumstances (including NPPA).
Back to top